Skip to content

Clinical trials

Phase 3 Dilatation, Pathologic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dilatation, Pathologic Phase: Phase 3 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20103
20141
20161
20181
20191
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status4
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ocuphire Pharma, Inc.3
Topcon Medical Systems, Inc.2
Ullevaal University Hospital2
Center for Sight, Sacramento, CA1
Crowd Health Research, LTD1
Glaukos Corporation1
Icahn School of Medicine at Mount Sinai1
Satya Pal Sharma1
University of California, San Diego1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dilatation, Pathologic13
Keratoconus4
Mydriasis3
Corneal Diseases2
Abortion, Missed1
Abortion, Spontaneous1
Bursitis1
Uterine Hemorrhage1

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.